Drug intelligence / Profile preview

Coldnil Total

Development stage
Unknown
Lead developer
Modi Lifecare Industries
Modality
Small Molecules
Administration
Oral
01

Overview

Coldnil Total is a multi-ingredient oral combination medication manufactured by Modi Lifecare Industries, designed for the symptomatic treatment of the common cold, influenza, and associated respiratory allergies. The formulation typically combines four active pharmaceutical ingredients: paracetamol, phenylephrine hydrochloride, chlorpheniramine maleate, and caffeine. Paracetamol serves as the primary analgesic and antipyretic agent, acting through the inhibition of prostaglandin synthesis. Phenylephrine hydrochloride functions as a decongestant by acting as a selective alpha-1 adrenergic receptor agonist, leading to vasoconstriction in the nasal mucosa. Chlorpheniramine maleate is a first-generation antihistamine that antagonizes H1 receptors to alleviate symptoms such as sneezing, rhinorrhea, and itchy eyes. Caffeine is included as an adjuvant to enhance the analgesic efficacy of paracetamol and to mitigate the sedative effects commonly associated with first-generation antihistamines. As a generic product, Coldnil Total is marketed for the relief of fever, headache, body aches, and nasal congestion.

Brand names
Coldnil Total
Other names
Coldnil
02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)ADRA1A (α1A)HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Coldnil Total.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coldnil Total.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call